Skip to main content

Advertisement

SpringerLink
Log in

Expression of GPC3 protein and its significance in lung squamous cell carcinoma

  • Original Paper
  • Published:
Medical Oncology Aims and scope Submit manuscript

Abstract

The purpose of this study was to investigate GPC3 gene expression in lung squamous cell carcinoma tissue and its correlation with clinical and tumor characteristics. Using RT–PCR, the presence of GPC3 gene expression was detected in cancer tissue and adjacent normal tissue in 66 cases of lung squamous cell carcinoma and positive rates were calculated. Using Western blot, changes in GPC3 protein expression were detected in lung squamous cell carcinoma and adjacent normal tissues. The percentage of tissue samples expressing GPC3 mRNA was significantly higher in lung squamous cell carcinoma than in adjacent normal tissue (P < 0.05). This percentage was also significantly higher for cases with lymph node metastasis than for those without lymph node metastasis (P < 0.05). Further, the percentage of samples expressing GPC3 mRNA was higher with lowering degrees of tumor differentiation (P < 0.05). Rates of GPC3 expression were, however, independent of patient gender, age, and tumor size (P > 0.05). The expression of GPC3 protein in lung squamous cell carcinoma was significantly higher than that in adjacent normal tissues (P < 0.05). The expression in cases with lymph node metastasis was significantly higher than in those without lymph node metastasis (P < 0.05), and GPC3 protein expression increased with lowering degrees of tumor differentiation (P < 0.05). Further investigation is warranted for the association of initiation, development, invasion, and metastasis of disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Shao WL, Wang DY, He JX. The role of gene expression profiling in early-stage non-small cell lung cancer. J Thorac Dis. 2010;2:89–99.

    PubMed  CAS  Google Scholar 

  2. Gonzalez AD, Kaya M, Shi W, Song H, Testa JR, Penn LZ, Filmus J. OCI-5/GPC3, a glypican encoded by a gene that is mutated in the Simpson-Golabi-Behmel overgrowth syndrome, induces apoptosis in a cell line-specific manner. J Cell Biol. 1998;141:1407–14.

    Article  PubMed  CAS  Google Scholar 

  3. Yamauchi N, Watanabe A, Hishinuma M, Ohashi K, Midorikawa Y, Morishita Y, Niki T, Shibahara J, Mori M, Makuuchi M, et al. The glypican 3 oncofetal protein is a promising diagnostic marker for hepatocellular carcinoma. Mod Pathol. 2005;18:1591–8.

    PubMed  CAS  Google Scholar 

  4. Kandil D, Leiman G, Allegretta M, Evans M. Glypican-3 protein expression in primary and metastatic melanoma: a combined immunohistochemistry and immunocytochemistry study. Cancer Cytopathol. 2009;117:271–8.

    Article  CAS  Google Scholar 

  5. Oishi C, Baba T, Kubota Y, Shimotsuma Y, Kitamura K, Honma T, Ikegami A, Inokuchi M, Umeda T, Yoshida H, et al. Two cases of gastric cancer expressing Glypican 3, but producing AFP with different lectin affinity. Nippon Shokakibyo Gakkai Zasshi. 2009;106:805–12.

    PubMed  Google Scholar 

  6. Buchanan C, Stigliano I, Garay-Malpartida HM, Rodrigues Gomes L, Puricelli L, Sogayar MC, Bal de Kier Joffe E, Peters MG. Glypican-3 reexpression regulates apoptosis in murine adenocarcinoma mammary cells modulating PI3 K/Akt and p38MAPK signaling pathways. Breast Cancer Res Treat. 2010;119:559–74.

    Article  PubMed  CAS  Google Scholar 

  7. Maeda D, Ota S, Takazawa Y, Aburatani H, Nakagawa S, Yano T, Taketani Y, Kodama T, Fukayama M. Glypican-3 expression in clear cell adenocarcinoma of the ovary. Mod Pathol. 2009;22:824–32.

    PubMed  CAS  Google Scholar 

  8. Toretsky JA, Zitomersky NL, Eskenazi AE, Voigt RW, Strauch ED, Sun CC, Huber R, Meltzer SJ, Schlessinger D. Glypican-3 expression in Wilms tumor and hepatoblastoma. J Pediatr Hematol Oncol. 2001;23:496–9.

    Article  PubMed  CAS  Google Scholar 

  9. Murthy SS, Shen T, De Rienzo A, Lee WC, Ferriola PC, Jhanwar SC, Mossman BT, Filmus J, Testa JR. Expression of GPC3, an X-linked recessive overgrowth gene, is silenced in malignant mesothelioma. Oncogene. 2000;19:410–6.

    Article  PubMed  CAS  Google Scholar 

  10. Nakatsura T, Kageshita T, Ito S, Wakamatsu K, Monji M, Ikuta Y, Senju S, Ono T, Nishimura Y. Identification of glypican-3 as a novel tumor marker for melanoma. Clin Cancer Res. 2004;10:6612–21.

    Article  PubMed  CAS  Google Scholar 

  11. Peters MG, Farias E, Colombo L, Filmus J, Puricelli L, Bal de Kier Joffe E. Inhibition of invasion and metastasis by glypican-3 in a syngeneic breast cancer model. Breast Cancer Res Treat. 2003;80:221–32.

    Article  PubMed  CAS  Google Scholar 

  12. Lin H, Huber R, Schlessinger D, Morin PJ. Frequent silencing of the GPC3 gene in ovarian cancer cell lines. Cancer Res. 1999;59:807–10.

    PubMed  CAS  Google Scholar 

  13. Powell CA, Xu G, Filmus J, Busch S, Brody JS, Rothman PB. Oligonucleotide microarray analysis of lung adenocarcinoma in smokers and nonsmokers identifies GPC3 as a potential lung tumor suppressor. Chest. 2002;121(3 Suppl):6S–7S.

    Article  PubMed  Google Scholar 

  14. Kim H, Xu GL, Borczuk AC, Busch S, Filmus J, Capurro M, Brody JS, Lange J, D’Armiento JM, Rothman PB, et al. The heparan sulfate proteoglycan GPC3 is a potential lung tumor suppressor. Am J Respir Cell Mol Biol. 2003;29:694–701.

    Article  PubMed  CAS  Google Scholar 

  15. Baumhoer D, Tornillo L, Stadlmann S, Roncalli M, Diamantis EK, Terracciano LM. Glypican 3 expression in human nonneoplastic, preneoplastic, and neoplastic tissues: a tissue microarray analysis of 4, 387 tissue samples. Am J Clin Pathol. 2008;129:899–906.

    Article  PubMed  Google Scholar 

  16. Filmus J, Capurro M, Rast J. Glypicans. Genome Biol. 2008;9:224.

    Article  PubMed  Google Scholar 

  17. Buchanan C, Stigliano I, Garay-Malpartida HM, Rodrigues Gomes L, Puricelli L, Sogayar MC, Bal de Kier Joffe E, Peters MG. Glypican-3 reexpression regulates apoptosis in murine adenocarcinoma mammary cells modulating PI3 K/Akt and p38MAPK signaling pathways. Breast Cancer Res Treat. 2010;119:559–74.

    Article  PubMed  CAS  Google Scholar 

  18. Zynger DL, Dimov ND, Luan C, Teh BT, Yang XJ. Glypican 3: a novel marker in testicular germ cell tumors. Am J Surg Pathol. 2006;30:1570–5.

    Article  PubMed  Google Scholar 

  19. Akutsu N, Yamamoto H, Sasaki S, Taniguchi H, Arimura Y, Imai K. Shinomura Y: Association of glypican-3 expression with growth signaling molecules in hepatocellular carcinoma. World J Gastroenterol. 2010;16:3521–8.

    Article  PubMed  CAS  Google Scholar 

  20. Suzuki M, Sugimoto K, Tanaka J, Tameda M, Inagaki Y, Kusagawa S, Nojiri K, Beppu T, Yoneda K, Yamamoto N, et al. Up-regulation of glypican-3 in human hepatocellular carcinoma. Anticancer Res. 2010;30:5055–61.

    PubMed  CAS  Google Scholar 

  21. Ho M, Kim H. Glypican-3: a new target for cancer immunotherapy. Eur J Cancer. 2011;47:333–8.

    Article  PubMed  CAS  Google Scholar 

  22. Zhu ZW, Friess H, Wang L, Abou-Shady M, Zimmermann A, Lander AD, Korc M, Kleeff J, Buchler MW. Enhanced glypican-3 expression differentiates the majority of hepatocellular carcinomas from benign hepatic disorders. Gut. 2001;48:558–64.

    Article  PubMed  CAS  Google Scholar 

  23. Pilia G, Hughes-Benzie RM, MacKenzie A, Baybayan P, Chen EY, Huber R, Neri G, Cao A, Forabosco A, Schlessinger D. Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndrome. Nat Genet. 1996;12:241–7.

    Article  PubMed  CAS  Google Scholar 

  24. Umezu T, Shibata K, Kajiyama H, Yamamoto E, Nawa A, Kikkawa F. Glypican-3 expression predicts poor clinical outcome of patients with early-stage clear cell carcinoma of the ovary. J Clin Pathol. 2010;63:962–6.

    Article  PubMed  CAS  Google Scholar 

  25. Xiang YY, Ladeda V, Filmus J. Glypican-3 expression is silenced in human breast cancer. Oncogene. 2001;20:7408–12.

    Article  PubMed  CAS  Google Scholar 

  26. Song HH, Shi W, Xiang YY, Filmus J. The loss of glypican-3 induces alterations in Wnt signaling. J Biol Chem. 2005;280:2116–25.

    Article  PubMed  CAS  Google Scholar 

  27. Lee EH, Chari R, Lam A, Ng RT, Yee J, English J, Evans KG, Macaulay C, Lam S, Lam WL. Disruption of the non-canonical WNT pathway in lung squamous cell carcinoma. Clin Med Oncol. 2008;2:169–79.

    CAS  Google Scholar 

Download references

Conflict of interest

The authors have no commercial, proprietary, or financial interest in the products or companies described in this article.

Author information

Authors and Affiliations

  1. Department of Thoracic Surgery, Shanghai Chest Hospital, Shanghai Jiaotong University, No. 241, West Huaihai Rd, Shanghai, 200030, China

    Qiang Lin, Xu-feng Pan, Jun-feng Gen, Chun-yu Ji & Ming Chen

  2. Department of Pulmonary Medicine, Shanghai Chest Hospital, Shanghai Jiaotong University, Shanghai, People’s Republic of China

    Li-wen Xiong

  3. Lung Cancer Institute, Shanghai Chest Hospital, Shanghai Jiaotong University, Shanghai, People’s Republic of China

    Guo-liang Bao, Hui-fang Sha & Jiu-xian Feng

Authors
  1. Qiang Lin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Li-wen Xiong
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Xu-feng Pan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jun-feng Gen
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Guo-liang Bao
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Hui-fang Sha
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Jiu-xian Feng
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Chun-yu Ji
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Ming Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Qiang Lin.

Additional information

Qiang Lin and Li-wen Xiong contributed equally to this article.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lin, Q., Xiong, Lw., Pan, Xf. et al. Expression of GPC3 protein and its significance in lung squamous cell carcinoma. Med Oncol 29, 663–669 (2012). https://doi.org/10.1007/s12032-011-9973-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12032-011-9973-1

Keywords

Search

Navigation